期刊文献+

慢性充血性心力衰竭患者血清生长分化因子-15测定的临床意义 被引量:3

Clinical significance of serum levels of growth differentiation factor-15(GDF-15) in patients with chronic congestive heart failure
下载PDF
导出
摘要 目的探讨慢性充血性心力衰竭(CHF)患者血清生长分化因子-15(GDF-15)水平的变化,并探讨其临床意义。方法选择CHF患者60例,测定血清GDF-15水平变化,并与30名健康对对照组进行比较。结果 CHD患者左室收缩末期内径(LVESD)、左室舒张末期内径(LVEDD)、心胸比值和血清GDF-15明显高于健康对照组,左室射血分数(LVEF)明显低于健康对照组(P<0.01);随着NYHA分级的增高,CHF患者血清GDF-15水平相应提高(P<0.05或0.01);血清GDF-15和LVEF呈负相关(γ=-0.658,P<0.01),和LVEDD、LVESD和心胸比值呈正相关(γ=0.588,0.596,0.621,P<0.01)。结论血清GDF-15可反映心功能的状态,并对CHF的诊断和病情判定有重要意义,有望成为CHF的新生标志物。 Objective To investigate the changes and clinical significance of serum levels of growth differentiation factor--15(GDF--15) in patients with chronic congestive heart failure. Methods Total of 60 patients with chronic congestive heart failure were matched with 30 healthy controls and the serum levels changes of GDF--15 were detected. Results The left ventrieular end systolic diameter(LVESD), left ventrieular end diastolic diameter(LVEDD), cardiothoracic ratio and serum GDF--15 in researched groups was higher than the controls and the left ventricular ejection fraction(LVEF) was lower than the controls (P 〈 0.01) ; The serum levels of GDF--15 in patients with CHF rose as the NYHA classifica- tion went up and it had statistically significance (P 〈 0.05 or 0.01) ; the serum levels of GDF--15 were significant negative correlation with LVEF (r=-0. 658, P 〈 0.01) and was significant positive correla- tion with LVEDD, LVESD and cardiothoracic ratio (r = 0. 588, 0. 596, 0. 621, P 〈 0.01). Conclusions Serum levels of GDF--15 may serve as a good biomarker for reflecting cardiac status and as an important biomarker to diagnose and determine the state of CHF. It may he a new marker for CHF.
出处 《齐齐哈尔医学院学报》 2012年第14期1850-1851,共2页 Journal of Qiqihar Medical University
关键词 心力衰竭 慢性 生长分化因子-15(GDF-15) Heart failure Chronic Growth differentiation factor--15(GDF--15)
  • 相关文献

参考文献7

  • 1Brown DA, Breit SN, Buring J, et al. Concentration in plasma of maerophage inhibitory cytokine- land risk of cardiovascular events in women: a nested case- control study[J]. Lancet, 2002,359(9324) :2 159-2 163.
  • 2魏罡,田国忠,李梅秀.生长分化因子-15与心力衰竭的研究进展[J].中国医药导刊,2012,14(3):465-467. 被引量:1
  • 3Ago T, Sadoshina J. GDF- 15, a cardioprotective TGF- su- perfamily protein[J]. Cite Res, 2006,98 : 294 (2) : 342-360.
  • 4Kempf T, Horn-Wichmann R, Brabant G, et al. Circulating concentrations of growth-differentiation factor 15 in apparently healthy elderly individuals and patients with chronic heart fail- ure as assessed by a new immunoradiometric sandwich assay [J]. Clin Chem,2007,53(2) :284-291.
  • 5Jian X, Thomas RK, John NL, et al. GDF- 15/MIC- 1 func- tions as a protective and antihypertrophic factor released from the myoeardium in association with SMAD protein activation [J]. Ore Res,2006,98(2) :342-350.
  • 6Kempf T, Wollert KC. Growth- differentiation factor- 15 in heart faiture[J]. Heart Fail C1in,2009(5):537-547.
  • 7Kempf T,von Haehling S, Peter T, et al. Prognostic utility of growth differentiation factor-15 in patients with chronic heart failure[J]. J Am Coil Cardiol,2007,50(11) :1 054-1 060.

二级参考文献19

  • 1Ago T,Sadoshima J.GDF15,a cardioprotective TGF-super family protein[J].Circ Res,2006;98:294,342-360.
  • 2Staff A.C.,Trovik J.,Eriksson A.G.Z.,et al.Elevated plasma growth differentiation factor-15 correlates with lymph node metastases and poor survival in endometrial cancer[J].Clinical Cancer Research,2011;17(14):4825-4833.
  • 3Sugulle M,Dechend R,Herse F.et al.Circulating and placental growthdifferentiation factor 15 in preeclampsia and in pregnancy complicated by diabetes mellitus[J].Hypertension,2009;54(1):106-112.
  • 4Rley FM,Costello DJ,Sullivan AM.Neuroprotective effect of delayed admin is tration of growth differentiation factor 15 in the partial lesion model of Park in sons disease[J].Exp Neurol,2004;185:281-289.
  • 5Anand I.S.,Kempf T.,Rector T.S.,et al.Serial measurement of growthdifferentiation factor-15 in heart failure:Relation to disease severity and prognosis in the valsartan heart failure trial[J].Circulation,2010;122(14):1387-1395.
  • 6Eggers K.M.,Kempf T.,Lind L.,et al.Relations of growth-differentiation factor-15 to biomarkers reflecting vascular pathologies in a population-based sample of elderly subjects[J].Scandinavian Journal of Clinical and Laboratory Investigation,2012;72(1):45-51.
  • 7Füth R,Dinh W,Nickl W.et al.Soluble P-selectin and matrix metalloproteinase 2 levels are elevated in patients with diastolic dysfunction independent of glucose metabolism disorder or coronary artery disease[J].Experimental and Clinical Cardiology,2009;14(3):76-79.
  • 8Cheng J.-C,Chang H.-M,Leung P.C.K.Wild-type p53 attenuates cancer cell motility by inducing growth differentiation factor-15 expression[J].Endocrinolo gy,2011;152(8):2987-2995.
  • 9Li PX,Wong J,Ayed A,et al.Placental transforming growth factor-beta is a downstream mediator of the growth arrest and apoptotic response of tumor cells to DNA damage and p53 overexpression[J].J Biol Chem,2000;275(26):20127-20135.
  • 10Deryuck R,Zhang YE.Smad-dependent and Smad-independent pathways in TGFbetafamily signalling[J].Nature,2003;425:577-584.

同被引文献29

引证文献3

二级引证文献23

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部